Tag: Insulin
Cipla launches India’s only inhaled insulin, Afrezza
The launch of this product in India is expected to benefit many of the 10 crore adults currently living with diabetes mellitus
IIT Guwahati secures patent for innovative insulin production system
The novel system has potential for insulin production at lower costs and higher yields
Biocon gets six-month extension on insulin supply pact in Malaysia
The company was awarded the insulins supply contract for a three-year period in 2022 through April 2025
Cipla receives approval for distribution & marketing of inhaled insulin in...
As per the company, it is redefining diabetes treatment with an innovative, needle-free alternative that is tailored to meet patient needs in India
Biocon Biologics successfully completes integration of Viatris’ biosimilar business in 31...
In Europe, Biocon Biologics portfolio includes 7 biosimilars: Insulin Aspart and Insulin Glargine, Bevacizumab, Pegfilgrastim, Trastuzumab, Adalimumab, and Etanercept
USV partners Biogenomics to launch INSUQUICK, the first biosimilar Insulin Aspart...
INSUQUICK is 100% Made in India with the potential to improve treatment access for people with diabetes
Insulin pumps market to hit US$ 13.34 billion by 2032: Report
The Asia Pacific market is expected to rise at a high CAGR during the forecast period due to developing healthcare facilities and rising production of advanced insulin pumps
Insulin pumps market to hit US$ 13.34 billion by 2032
The Asia Pacific market is expected to rise at a high CAGR during the forecast period due to developing healthcare facilities
Insulin pumps market to hit US$ 13.34 billion by 2032, predicts report
Demand for patch insulin pumps is predicted to rise at a CAGR of 10% from 2022 to 2032
Diabetes Technology: Improving Care Through Innovation
Research indicates that continuous glucose monitoring has helped people with Type 2 diabetes either on long-acting insulin therapy or non-insulin OAD therapy, significantly reducing their HbA1c levels